In hepatitis C medicine, 'cure' has a precise clinical meaning — and knowing exactly what it covers helps set realistic expectations.
Terms used here
- Sustained virological response (SVR)
- the clinical term for confirmed absence of virus in the blood after treatment; the formal definition of a successful outcome
- Fibrosis
- accumulation of scar tissue in the liver as a result of sustained inflammation
- Cirrhosis
- advanced-stage fibrosis; the more severe end of liver scarring
The Term Clinicians Actually Use
When a clinician discusses a successful treatment outcome, the phrase they reach for is sustained virological response, often shortened to SVR. It means that after treatment ends, testing can detect no hepatitis C virus in the blood — and that this absence holds when testing is repeated some weeks later. Once SVR is confirmed, the virus is not expected to return from that infection. That is the clinical definition of cure, and it is a meaningful one.
The reason medicine uses its own language here rather than simply saying 'cured' is precision, not caution for its own sake. SVR describes something measurable and time-defined: a result confirmed at a specific point after the end of treatment. That specificity matters because it is the basis on which outcomes are assessed and compared across populations and studies. When you hear a clinician use it, they are being exact, not evasive.
What Ongoing Care Can Still Involve
SVR does not reset the liver to whatever state it was in before infection began. If the liver has accumulated significant scarring — a condition called fibrosis, or in its more advanced form cirrhosis — that structural change does not automatically reverse when the virus clears. How much monitoring or follow-up a person needs after SVR depends substantially on the state of their liver at the time treatment concludes. Someone whose liver shows little or no scarring occupies a different position from someone with more advanced fibrosis, and a clinician is the right person to explain what applies in any individual situation.
There is also one further distinction worth holding in mind. Clearing a hepatitis C infection does not produce lasting immunity the way some viral illnesses do. A person who has achieved SVR can, in principle, acquire hepatitis C again through a new blood-to-blood exposure. That is not a reason for alarm — it is simply a fact about how this particular virus works.
None of this diminishes what SVR represents. The word 'cure' is not an overstatement here: it describes a genuine, durable clearance of the virus, confirmed by testing, with no expectation of the original infection re-emerging. For most people who reach that result, liver health stabilises and in some cases gradually improves. What happens next — how often monitoring continues, and in what form — is a conversation to have with the clinician managing care, who can speak to the specifics of an individual's situation rather than to the general picture this guide describes.
General information only — not medical advice. Not affiliated with any clinic, laboratory, charity, campaign or pharmaceutical company. If you have questions about your own health, speak to a qualified clinician.